Overall market sentiment has been high on Adamis Pharmaceuticals Corp (ADMP) stock lately. ADMP receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With ADMP Stock Today?
Adamis Pharmaceuticals Corp (ADMP) stock is flat 0.3% while the S&P 500 is higher by 0.88% as of 2:45 PM on Monday, Oct 12. ADMP is flat $0.00 from the previous closing price of $0.98 on volume of 10,521,636 shares. Over the past year the S&P 500 is up 17.23% while ADMP is higher by 86.79%. ADMP lost -$0.52 per share in the over the last 12 months.
To screen for more stocks like Adamis Pharmaceuticals Corp click here.
More About Adamis Pharmaceuticals Corp
Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company. It is focused on developing and commercializing products in various therapeutic areas, including respiratory disease, allergy, and opioid overdose. Its SYMJEPI (epinephrine) Injection products are used in the emergency treatment of acute allergic reactions, including anaphylaxis.
Click Here to get the full Stock Score Report on Adamis Pharmaceuticals Corp (ADMP) Stock.
